WALTHAM, Mass.–(BUSINESS WIRE)–Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced the appointment of Kelley Dealhoy as Senior Vice President and Chief Business Officer. Ms. Dealhoy brings 20 years of life science leadership experience to the role, and her responsibilities will include developing and leading the Company’s business development efforts as well as supporting corporate strategy initiatives. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Orthopedic Power Tools and Consumables Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. Orthopedic Power Tools and Consumables Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, … [Read more…]

Pre-Clinical Research Could Lead to Rapid Development of Dopamine-Producing Neurons; Part of Company’s NIH-Funded Program Seeking Scalable Cell Replacement Therapy Approaches for Parkinson’s Disease Use of Non-Viral, Self-Amplifying RNA Enhanced and Lengthened Transcription Factor Expression, Driving the Signaling Required for Dopamine-Producing Neuron Development Findings Presented at 2022 International Society for Stem Cell Research Annual Meeting … [Read more…]

Highlights The C$2.9 billion transaction advances both LifeWorks and TELUS Health strategic plans to create the unparalleled leader in employee wellness The transaction has received the unanimous approval of LifeWorks’ Board of Directors and is subject to approval by LifeWorks shareholders LifeWorks shareholders will have option to receive C$33.00 per share in cash, TELUS shares … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Wrist Replacement Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030” report has been added to ResearchAndMarkets.com’s offering. The model discusses in detail the impact of COVID-19 on Wrist Replacement Devices market for the year 2020 and beyond. About 75% of the … [Read more…]

The new rechargeable Custom made by ReSound hearing aids give all day comfort and streaming with outstanding sound quality, even in the toughest listening environments. Custom made by ReSound will make people think again about hearing aids by offering the most advanced medical-grade technology in a smart, stylish design. BALLERUP, Denmark–(BUSINESS WIRE)–GN Hearing, the global … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Kurin Inc., the inventor and manufacturer of Kurin® blood culture collection sets, announced that the U.S. District Court for the District of Delaware has entered a judgment that Kurin does not infringe U.S. Patent No. 9,855,001 in the patent-infringement lawsuit Magnolia brought against Kurin. Magnolia earlier withdrew two other patents from the case, … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “China TAVR & TMV Market: Insights & Forecast with Potential Impact of COVID-19 (2022-2026)” report has been added to ResearchAndMarkets.com’s offering. The Chinese TAVR market is expected to reach US$1,669.14 million in 2026, growing at a CAGR of 55.50%, for the duration spanning 2022-2026. While, the TMV market in China is forecasted to … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Leadership Quadrant of Medical Battery Suppliers – 2022” report has been added to ResearchAndMarkets.com’s offering. The medical battery manufacture landscape is diverse and continually evolving. Major players in medical battery market have diversified product portfolios, strong geographical reach, and have made several strategic initiatives. The dynamics of the medical battery market extends beyond … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2028” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive insight on clinical and non-clinical factors that are driving the global CFTR Modulators market and its impact on the global pharmaceutical market landscape. The approval of the first CF transmembrane … [Read more…]